Walleye Trading LLC Avadel Pharmaceuticals PLC Put Options Transaction History

Walleye Trading LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 16, 2022	BUY	$5.46 - $8.29 $546 - $828	100 New	100 $1,000
Q2 2021 Aug 16, 2021	SELL	$6.73 - $9.05 $16,152 - $21,720	-2,400 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$6.61 - $10.07 $123,607 - $188,309	-18,700 Reduced 88.63%	2,400 $22,000
Q4 2020 Feb 16, 2021	BUY	$5.03 - $7.95 $87,019 - $137,535	17,300 Added 455.26%	21,100 $141,000
Q4 2019 Feb 14, 2020	BUY	$3.34 - $7.7 $12,692 - $29,260	3,800 New	3,800 $29,000

1.07M

Ticker AVDL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 60,581,300
Market Cap $650M
Description
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.